Loading…

Specific antibody filter (SAF) binding capacity enhancement to remove anti-A antibodies

Removal of Anti‐A/B antibodies prior to ABO‐incompatible transplantation can prevent hyperacute organ rejection. We are developing a specific antibody filter (SAF) device to selectively remove ABO blood group antibodies from the whole blood by utilizing immunoaffinity adsorption. The device consists...

Full description

Saved in:
Bibliographic Details
Published in:Journal of biomedical materials research. Part B, Applied biomaterials Applied biomaterials, 2010-11, Vol.95B (2), p.475-480
Main Authors: Gautam, Shalini, Korchagina, Elena Y., Bovin, Nicolai V., Federspiel, William J.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3447-374f9babf79ed1689f22bcdc78aeb82283c9b2a5c75c18bc09cad12b227e309f3
cites cdi_FETCH-LOGICAL-c3447-374f9babf79ed1689f22bcdc78aeb82283c9b2a5c75c18bc09cad12b227e309f3
container_end_page 480
container_issue 2
container_start_page 475
container_title Journal of biomedical materials research. Part B, Applied biomaterials
container_volume 95B
creator Gautam, Shalini
Korchagina, Elena Y.
Bovin, Nicolai V.
Federspiel, William J.
description Removal of Anti‐A/B antibodies prior to ABO‐incompatible transplantation can prevent hyperacute organ rejection. We are developing a specific antibody filter (SAF) device to selectively remove ABO blood group antibodies from the whole blood by utilizing immunoaffinity adsorption. The device consists of ultrafiltration hollow fiber membranes with synthetic antigens specific to bind blood group antibodies immobilized on the inner lumenal walls of the fibers. The aim of this study was to evaluate the effect of antigen molecular weight and surface activation process to increase the antibody binding capacity of the fiber membrane surface. A new higher molecular weight antigen Atri‐pNSA‐1000 compared with Atri‐pNPA‐30 (A‐trisaccharide (Atri) conjugated to activated polymers of Mol. wt. 1000 kDa and 30 kDa, respectively) was employed to improve accessibility of the antigen to bind antibodies. Also, a cyanogen bromide (CNBr) based surface activation method mediated by TEA in neutral pH medium was used to enhance the number of active sites for antigen binding compared to a strong basic medium of NaOH. Using a CNBr/TEA activation method and by immobilizing Atri‐pNSA‐1000 antigen, an antibody binding capacity (∼0.01 monoclonal anti‐A IgM nmol/cm2) was achieved on the fiber surface. This binding capacity was sufficient to reduce monoclonal antibody titer from 1:128 to final titer below 1:4 with a surface area to volume ratio that is similar to commercial dialysis device (∼1.1 m2 surface area for an average body blood volume of 5 L). © 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2010.
doi_str_mv 10.1002/jbm.b.31707
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_883045928</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1671274801</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3447-374f9babf79ed1689f22bcdc78aeb82283c9b2a5c75c18bc09cad12b227e309f3</originalsourceid><addsrcrecordid>eNp9kUtPGzEURq0KVCDtqns0Eguo0KR-jGN7mUaEh0IrFSqWlu25Q53OI7Un0Px7DCFZsGB17-J8R_fqQ-gLwUOCMf02t83QDhkRWHxA-4RzmhdKkp3tLtgeOohxnuAR5uwj2qNYCqmI2Ed3NwtwvvIuM23vbVeussrXPYTs5GY8_ZpZ35a-vc-cWRjn-1UG7R_TOmig7bO-ywI03QO8hPPxxuEhfkK7lakjfH6dA_R7enY7uchnP88vJ-NZ7lhRiJyJolLW2EooKMlIqopS60onpAErKZXMKUsNd4I7Iq3DypmSUEupAIZVxQboeO1dhO7fEmKvGx8d1LVpoVtGLSXDBVdJNEAn75JkJAgVhcQkoUdv0Hm3DG36QzPMRTqzkCxRp2vKhS7GAJVeBN-YsNIE6-dmdGpGW_3STKIPX51L20C5ZTdVJICsgUdfw-o9l776fr2R5uuMjz3832ZM-KtHggmu736ca1LMria3U65_sScoUqbX</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3057689483</pqid></control><display><type>article</type><title>Specific antibody filter (SAF) binding capacity enhancement to remove anti-A antibodies</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Gautam, Shalini ; Korchagina, Elena Y. ; Bovin, Nicolai V. ; Federspiel, William J.</creator><creatorcontrib>Gautam, Shalini ; Korchagina, Elena Y. ; Bovin, Nicolai V. ; Federspiel, William J.</creatorcontrib><description>Removal of Anti‐A/B antibodies prior to ABO‐incompatible transplantation can prevent hyperacute organ rejection. We are developing a specific antibody filter (SAF) device to selectively remove ABO blood group antibodies from the whole blood by utilizing immunoaffinity adsorption. The device consists of ultrafiltration hollow fiber membranes with synthetic antigens specific to bind blood group antibodies immobilized on the inner lumenal walls of the fibers. The aim of this study was to evaluate the effect of antigen molecular weight and surface activation process to increase the antibody binding capacity of the fiber membrane surface. A new higher molecular weight antigen Atri‐pNSA‐1000 compared with Atri‐pNPA‐30 (A‐trisaccharide (Atri) conjugated to activated polymers of Mol. wt. 1000 kDa and 30 kDa, respectively) was employed to improve accessibility of the antigen to bind antibodies. Also, a cyanogen bromide (CNBr) based surface activation method mediated by TEA in neutral pH medium was used to enhance the number of active sites for antigen binding compared to a strong basic medium of NaOH. Using a CNBr/TEA activation method and by immobilizing Atri‐pNSA‐1000 antigen, an antibody binding capacity (∼0.01 monoclonal anti‐A IgM nmol/cm2) was achieved on the fiber surface. This binding capacity was sufficient to reduce monoclonal antibody titer from 1:128 to final titer below 1:4 with a surface area to volume ratio that is similar to commercial dialysis device (∼1.1 m2 surface area for an average body blood volume of 5 L). © 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2010.</description><identifier>ISSN: 1552-4973</identifier><identifier>ISSN: 1552-4981</identifier><identifier>EISSN: 1552-4981</identifier><identifier>DOI: 10.1002/jbm.b.31707</identifier><identifier>PMID: 20878917</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>ABO Blood-Group System - immunology ; ABO system ; Adsorption ; Antibodies ; Antibodies - blood ; Antibodies - isolation &amp; purification ; antibody filter ; Antigens ; Antigens - chemistry ; Antigens - immunology ; Binding ; Biomedical materials ; Blood groups ; Blood volume ; Cyanogen ; Devices ; Dialysis ; fiber membranes ; Fibers ; Filtration - methods ; Graft rejection ; Hollow fiber membranes ; immunoaffinity absorption ; Immunoglobulin M ; Molecular Weight ; Monoclonal antibodies ; Oligosaccharides ; Polymers ; regenerative medicine ; Sodium hydroxide ; Surface activation ; Surface area ; Surface chemistry ; Surgical implants ; Ultrafiltration</subject><ispartof>Journal of biomedical materials research. Part B, Applied biomaterials, 2010-11, Vol.95B (2), p.475-480</ispartof><rights>Copyright © 2010 Wiley Periodicals, Inc.</rights><rights>2010 Wiley Periodicals, Inc.</rights><rights>Copyright Wiley Subscription Services, Inc. Nov 2010</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3447-374f9babf79ed1689f22bcdc78aeb82283c9b2a5c75c18bc09cad12b227e309f3</citedby><cites>FETCH-LOGICAL-c3447-374f9babf79ed1689f22bcdc78aeb82283c9b2a5c75c18bc09cad12b227e309f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20878917$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gautam, Shalini</creatorcontrib><creatorcontrib>Korchagina, Elena Y.</creatorcontrib><creatorcontrib>Bovin, Nicolai V.</creatorcontrib><creatorcontrib>Federspiel, William J.</creatorcontrib><title>Specific antibody filter (SAF) binding capacity enhancement to remove anti-A antibodies</title><title>Journal of biomedical materials research. Part B, Applied biomaterials</title><addtitle>J. Biomed. Mater. Res</addtitle><description>Removal of Anti‐A/B antibodies prior to ABO‐incompatible transplantation can prevent hyperacute organ rejection. We are developing a specific antibody filter (SAF) device to selectively remove ABO blood group antibodies from the whole blood by utilizing immunoaffinity adsorption. The device consists of ultrafiltration hollow fiber membranes with synthetic antigens specific to bind blood group antibodies immobilized on the inner lumenal walls of the fibers. The aim of this study was to evaluate the effect of antigen molecular weight and surface activation process to increase the antibody binding capacity of the fiber membrane surface. A new higher molecular weight antigen Atri‐pNSA‐1000 compared with Atri‐pNPA‐30 (A‐trisaccharide (Atri) conjugated to activated polymers of Mol. wt. 1000 kDa and 30 kDa, respectively) was employed to improve accessibility of the antigen to bind antibodies. Also, a cyanogen bromide (CNBr) based surface activation method mediated by TEA in neutral pH medium was used to enhance the number of active sites for antigen binding compared to a strong basic medium of NaOH. Using a CNBr/TEA activation method and by immobilizing Atri‐pNSA‐1000 antigen, an antibody binding capacity (∼0.01 monoclonal anti‐A IgM nmol/cm2) was achieved on the fiber surface. This binding capacity was sufficient to reduce monoclonal antibody titer from 1:128 to final titer below 1:4 with a surface area to volume ratio that is similar to commercial dialysis device (∼1.1 m2 surface area for an average body blood volume of 5 L). © 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2010.</description><subject>ABO Blood-Group System - immunology</subject><subject>ABO system</subject><subject>Adsorption</subject><subject>Antibodies</subject><subject>Antibodies - blood</subject><subject>Antibodies - isolation &amp; purification</subject><subject>antibody filter</subject><subject>Antigens</subject><subject>Antigens - chemistry</subject><subject>Antigens - immunology</subject><subject>Binding</subject><subject>Biomedical materials</subject><subject>Blood groups</subject><subject>Blood volume</subject><subject>Cyanogen</subject><subject>Devices</subject><subject>Dialysis</subject><subject>fiber membranes</subject><subject>Fibers</subject><subject>Filtration - methods</subject><subject>Graft rejection</subject><subject>Hollow fiber membranes</subject><subject>immunoaffinity absorption</subject><subject>Immunoglobulin M</subject><subject>Molecular Weight</subject><subject>Monoclonal antibodies</subject><subject>Oligosaccharides</subject><subject>Polymers</subject><subject>regenerative medicine</subject><subject>Sodium hydroxide</subject><subject>Surface activation</subject><subject>Surface area</subject><subject>Surface chemistry</subject><subject>Surgical implants</subject><subject>Ultrafiltration</subject><issn>1552-4973</issn><issn>1552-4981</issn><issn>1552-4981</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNp9kUtPGzEURq0KVCDtqns0Eguo0KR-jGN7mUaEh0IrFSqWlu25Q53OI7Un0Px7DCFZsGB17-J8R_fqQ-gLwUOCMf02t83QDhkRWHxA-4RzmhdKkp3tLtgeOohxnuAR5uwj2qNYCqmI2Ed3NwtwvvIuM23vbVeussrXPYTs5GY8_ZpZ35a-vc-cWRjn-1UG7R_TOmig7bO-ywI03QO8hPPxxuEhfkK7lakjfH6dA_R7enY7uchnP88vJ-NZ7lhRiJyJolLW2EooKMlIqopS60onpAErKZXMKUsNd4I7Iq3DypmSUEupAIZVxQboeO1dhO7fEmKvGx8d1LVpoVtGLSXDBVdJNEAn75JkJAgVhcQkoUdv0Hm3DG36QzPMRTqzkCxRp2vKhS7GAJVeBN-YsNIE6-dmdGpGW_3STKIPX51L20C5ZTdVJICsgUdfw-o9l776fr2R5uuMjz3832ZM-KtHggmu736ca1LMria3U65_sScoUqbX</recordid><startdate>201011</startdate><enddate>201011</enddate><creator>Gautam, Shalini</creator><creator>Korchagina, Elena Y.</creator><creator>Bovin, Nicolai V.</creator><creator>Federspiel, William J.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QF</scope><scope>7QO</scope><scope>7QQ</scope><scope>7SC</scope><scope>7SE</scope><scope>7SP</scope><scope>7SR</scope><scope>7T7</scope><scope>7TA</scope><scope>7TB</scope><scope>7U5</scope><scope>8BQ</scope><scope>8FD</scope><scope>C1K</scope><scope>F28</scope><scope>FR3</scope><scope>H8D</scope><scope>H8G</scope><scope>JG9</scope><scope>JQ2</scope><scope>K9.</scope><scope>KR7</scope><scope>L7M</scope><scope>L~C</scope><scope>L~D</scope><scope>P64</scope></search><sort><creationdate>201011</creationdate><title>Specific antibody filter (SAF) binding capacity enhancement to remove anti-A antibodies</title><author>Gautam, Shalini ; Korchagina, Elena Y. ; Bovin, Nicolai V. ; Federspiel, William J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3447-374f9babf79ed1689f22bcdc78aeb82283c9b2a5c75c18bc09cad12b227e309f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>ABO Blood-Group System - immunology</topic><topic>ABO system</topic><topic>Adsorption</topic><topic>Antibodies</topic><topic>Antibodies - blood</topic><topic>Antibodies - isolation &amp; purification</topic><topic>antibody filter</topic><topic>Antigens</topic><topic>Antigens - chemistry</topic><topic>Antigens - immunology</topic><topic>Binding</topic><topic>Biomedical materials</topic><topic>Blood groups</topic><topic>Blood volume</topic><topic>Cyanogen</topic><topic>Devices</topic><topic>Dialysis</topic><topic>fiber membranes</topic><topic>Fibers</topic><topic>Filtration - methods</topic><topic>Graft rejection</topic><topic>Hollow fiber membranes</topic><topic>immunoaffinity absorption</topic><topic>Immunoglobulin M</topic><topic>Molecular Weight</topic><topic>Monoclonal antibodies</topic><topic>Oligosaccharides</topic><topic>Polymers</topic><topic>regenerative medicine</topic><topic>Sodium hydroxide</topic><topic>Surface activation</topic><topic>Surface area</topic><topic>Surface chemistry</topic><topic>Surgical implants</topic><topic>Ultrafiltration</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gautam, Shalini</creatorcontrib><creatorcontrib>Korchagina, Elena Y.</creatorcontrib><creatorcontrib>Bovin, Nicolai V.</creatorcontrib><creatorcontrib>Federspiel, William J.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Aluminium Industry Abstracts</collection><collection>Biotechnology Research Abstracts</collection><collection>Ceramic Abstracts</collection><collection>Computer and Information Systems Abstracts</collection><collection>Corrosion Abstracts</collection><collection>Electronics &amp; Communications Abstracts</collection><collection>Engineered Materials Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Materials Business File</collection><collection>Mechanical &amp; Transportation Engineering Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ANTE: Abstracts in New Technology &amp; Engineering</collection><collection>Engineering Research Database</collection><collection>Aerospace Database</collection><collection>Copper Technical Reference Library</collection><collection>Materials Research Database</collection><collection>ProQuest Computer Science Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Civil Engineering Abstracts</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Computer and Information Systems Abstracts – Academic</collection><collection>Computer and Information Systems Abstracts Professional</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Journal of biomedical materials research. Part B, Applied biomaterials</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gautam, Shalini</au><au>Korchagina, Elena Y.</au><au>Bovin, Nicolai V.</au><au>Federspiel, William J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Specific antibody filter (SAF) binding capacity enhancement to remove anti-A antibodies</atitle><jtitle>Journal of biomedical materials research. Part B, Applied biomaterials</jtitle><addtitle>J. Biomed. Mater. Res</addtitle><date>2010-11</date><risdate>2010</risdate><volume>95B</volume><issue>2</issue><spage>475</spage><epage>480</epage><pages>475-480</pages><issn>1552-4973</issn><issn>1552-4981</issn><eissn>1552-4981</eissn><abstract>Removal of Anti‐A/B antibodies prior to ABO‐incompatible transplantation can prevent hyperacute organ rejection. We are developing a specific antibody filter (SAF) device to selectively remove ABO blood group antibodies from the whole blood by utilizing immunoaffinity adsorption. The device consists of ultrafiltration hollow fiber membranes with synthetic antigens specific to bind blood group antibodies immobilized on the inner lumenal walls of the fibers. The aim of this study was to evaluate the effect of antigen molecular weight and surface activation process to increase the antibody binding capacity of the fiber membrane surface. A new higher molecular weight antigen Atri‐pNSA‐1000 compared with Atri‐pNPA‐30 (A‐trisaccharide (Atri) conjugated to activated polymers of Mol. wt. 1000 kDa and 30 kDa, respectively) was employed to improve accessibility of the antigen to bind antibodies. Also, a cyanogen bromide (CNBr) based surface activation method mediated by TEA in neutral pH medium was used to enhance the number of active sites for antigen binding compared to a strong basic medium of NaOH. Using a CNBr/TEA activation method and by immobilizing Atri‐pNSA‐1000 antigen, an antibody binding capacity (∼0.01 monoclonal anti‐A IgM nmol/cm2) was achieved on the fiber surface. This binding capacity was sufficient to reduce monoclonal antibody titer from 1:128 to final titer below 1:4 with a surface area to volume ratio that is similar to commercial dialysis device (∼1.1 m2 surface area for an average body blood volume of 5 L). © 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2010.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>20878917</pmid><doi>10.1002/jbm.b.31707</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1552-4973
ispartof Journal of biomedical materials research. Part B, Applied biomaterials, 2010-11, Vol.95B (2), p.475-480
issn 1552-4973
1552-4981
1552-4981
language eng
recordid cdi_proquest_miscellaneous_883045928
source Wiley-Blackwell Read & Publish Collection
subjects ABO Blood-Group System - immunology
ABO system
Adsorption
Antibodies
Antibodies - blood
Antibodies - isolation & purification
antibody filter
Antigens
Antigens - chemistry
Antigens - immunology
Binding
Biomedical materials
Blood groups
Blood volume
Cyanogen
Devices
Dialysis
fiber membranes
Fibers
Filtration - methods
Graft rejection
Hollow fiber membranes
immunoaffinity absorption
Immunoglobulin M
Molecular Weight
Monoclonal antibodies
Oligosaccharides
Polymers
regenerative medicine
Sodium hydroxide
Surface activation
Surface area
Surface chemistry
Surgical implants
Ultrafiltration
title Specific antibody filter (SAF) binding capacity enhancement to remove anti-A antibodies
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T02%3A41%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Specific%20antibody%20filter%20(SAF)%20binding%20capacity%20enhancement%20to%20remove%20anti-A%20antibodies&rft.jtitle=Journal%20of%20biomedical%20materials%20research.%20Part%20B,%20Applied%20biomaterials&rft.au=Gautam,%20Shalini&rft.date=2010-11&rft.volume=95B&rft.issue=2&rft.spage=475&rft.epage=480&rft.pages=475-480&rft.issn=1552-4973&rft.eissn=1552-4981&rft_id=info:doi/10.1002/jbm.b.31707&rft_dat=%3Cproquest_cross%3E1671274801%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3447-374f9babf79ed1689f22bcdc78aeb82283c9b2a5c75c18bc09cad12b227e309f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3057689483&rft_id=info:pmid/20878917&rfr_iscdi=true